URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats

Author： Hasanein Parisa Parviz Mohsen Keshavarz Mansoor Roohbakhsh Ali

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.87, Iss.6, 2009-06, pp. : 432-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)

By Gifford A.N. Bruneus M. Lin S. Goutopoulos A. Makriyannis A. Volkow N.D. Gatley S.J.

European Journal of Pharmacology, Vol. 383, Iss. 1, 1999-10 ,pp. : 9-14

Elsevier

Access to resources Recommend Favorite

Fatty Acid Amide Hydrolase Inhibitors - Progress and Potential

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. : 545-558

Bentham Science Publishers

Access to resources Recommend Favorite

Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors

By Deng Hongfeng

Expert Opinion on Drug Discovery, Vol. 5, Iss. 10, 2010-10 ,pp. : 961-993

Informa Healthcare

Access to resources Recommend Favorite

Latest advances in the discovery of fatty acid amide hydrolase inhibitors

By Bisogno Tiziana Maccarrone Mauro

Expert Opinion on Drug Discovery, Vol. 8, Iss. 5, 2013-06 ,pp. : 509-522

Informa Healthcare

Access to resources Recommend Favorite

Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 759-772

Bentham Science Publishers

Access to resources Recommend Favorite